Reports Q4 revenue $737.64M, consensus $619.31M. “Our fourth quarter 2025 performance punctuates a milestone year for Legence (LGN),” said Jeff Sprau, CEO of Legence. “We achieved record quarterly revenues which increased by 34.6% year over year, driven almost entirely by organic growth. Total backlog and awarded contracts surged by 49% to a record $3.7 billion, led by Data Centers & Technology, along with State & Local Government and Life Science & Healthcare end markets. This exceptional performance is made possible by the dedication of our outstanding team of skilled labor and engineering professionals, who continue to execute at the highest and safest level for our customers.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Options Volatility and Implied Earnings Moves Today, March 27, 2026
- Notable companies reporting before tomorrow’s open
- Legence price target raised to $68 from $53 at Guggenheim
- LGN Earnings this Week: How Will it Perform?
- Legence Corp. Class A: Levered to Structural Pharma Reshoring and Data Center Capex Upswings, Justifying a Buy Rating
